Tatiana V. Karelina

Tatiana V. Karelina

Auto-generated profile, based on publicly available information

Tatiana V. Karelina

Sechenov Institute of Evolutionary Physiology and Biochemistry of the Russian Academy of Sciences, Torez pr. 44, Saint-Petersburg 194223, Russia

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 July 2020 in Biomolecules
Verified
Journal Article
Open access
PDF file
MIMaria A. Ivanova
Maria A. Ivanova
AKArina D. Kokorina
Arina D. Kokorina
PTPolina D. Timofeeva
Polina D. Timofeeva
TKTatiana V. Karelina
Tatiana V. Karelina
PAPolina A. A. Abushik
Polina A. A. Abushik
Sergei M AntonovSergei M Antonov
Sergei M Antonov
Pathological homocysteine (HCY) accumulation in the human plasma, known as hyperhomocysteinemia, exacerbates neurodegenerative diseases because, in the brain, this amino acid acts as a persistent N-methyl-d-aspartate receptor agonist. We studied the effects of 0.1–1 nM ouabain on intracellular Ca2+ signaling, mitochondrial inner membrane voltage (φmit), and cell viability in primary cultures of rat cortical neurons in glutamate and HCY neurotoxic insults. In addition, apoptosis-related protein expression and the involvement of some kinases in ouabain-mediated effects were evaluated. In short insults, HCY was less potent than glutamate as a neurotoxic agent and induced a 20% loss of φmit, whereas glutamate caused a 70% decrease of this value. Subnanomolar ouabain exhibited immediate and postponed neuroprotective effects on neurons. (1) Ouabain rapidly reduced the Ca2+ overload of neurons and loss of φmit evoked by glutamate and HCY that rescued neurons in short insults. (2) In prolonged 24 h excitotoxic insults, ouabain prevented neuronal apoptosis, triggering proteinkinase A and proteinkinase C dependent intracellular neuroprotective cascades for HCY, but not for glutamate. We, therefore, demonstrated here the role of PKC and PKA involving pathways in neuronal survival caused by ouabain in hyperhomocysteinemia, which suggests existence of different appropriate pharmacological treatment for hyperhomocysteinemia and glutamate excitotoxicity.

14 October 2020 in Biomolecules
Verified
Journal Article
Open access
PDF file
Dmitry A SibarovDmitry A Sibarov
Dmitry A Sibarov
SBSergei Boikov
Sergei Boikov
TKTatiana V. Karelina
Tatiana V. Karelina
Sergei M AntonovSergei M Antonov
Sergei M Antonov
Homocysteine (HCY) molecule combines distinct pharmacological properties as an agonist of N-methyl-d-aspartate receptors (NMDARs) and a reducing agent. Whereas NMDAR activation by HCY was elucidated, whether the redox modulation contributes to its action is unclear. Here, using patch-clamp recording and imaging of intracellular Ca2+, we study dithiothreitol (DTT) effects on currents and Ca2+ responses activated by HCY through native NMDARs and recombinant diheteromeric GluN1/2A, GluN1/2B, and GluN1/2C receptors. Within a wide range (1–800 μM) of [HCY]s, the concentration–activation relationships for recombinant NMDARs revealed a biphasicness. The high-affinity component obtained between 1 and 100 µM [HCY]s corresponding to the NMDAR activation was not affected by 1 mM DTT. The low-affinity phase observed at [HCY]s above 200 μM probably originated from thiol-dependent redox modulation of NMDARs. The reduction of NMDAR disulfide bonds by either 1 mM DTT or 1 mM HCY decreased GluN1/2A currents activated by HCY. In contrast, HCY-elicited GluN1/2B currents were enhanced due to the remarkable weakening of GluN1/2B desensitization. In fact, cleaving NMDAR disulfide bonds in neurons reversed the HCY-induced Ca2+ accumulation, making it dependent on GluN2B- rather than GluN2A-containing NMDARs. Thus, estimated concentrations for the HCY redox effects exceed those in the plasma during intermediate hyperhomocysteinemia but may occur during severe hyperhomocysteinemia.

6 August 2023 in Cells
Verified
Journal Article
Open access
PDF file
Dmitry A SibarovDmitry A Sibarov
Dmitry A Sibarov
ZZZoia Zhuravleva
Zoia Zhuravleva
MIMargarita A. Ilina
Margarita A. Ilina
SBSergei Boikov
Sergei Boikov
YSYulia D. Stepanenko
Yulia D. Stepanenko
Sergei M AntonovSergei M Antonov
Sergei M Antonov
Na/K-ATPase maintains transmembrane ionic gradients and acts as a signal transducer when bound to endogenous cardiotonic steroids. At subnanomolar concentrations, ouabain induces neuroprotection against calcium overload and apoptosis of neurons during excitotoxic stress. Here, the role of lipid rafts in interactions between Na/K-ATPase, sodium–calcium exchanger (NCX), and N-methy-D-aspartate receptors (NMDARs) was investigated. We analyzed 0.5–1-nanometer ouabain’s effects on calcium responses and miniature post-synaptic current (mEPSCs) frequencies of cortical neurons during the action of NMDA in rat primary culture and brain slices. In both objects, ouabain attenuated NMDA-evoked calcium responses and prevented an increase in mEPSC frequency, while the cholesterol extraction by methyl-β-cyclodextrin prevented the effects. The data support the conclusions that (i) ouabain-induced inhibition of NMDA-elicited calcium response involves both pre- and post-synapse, (ii) the presence of astrocytes in the tripartite synapse is not critical for the ouabain effects, which are found to be similar in cell cultures and brain slices, and (iii) ouabain action requires the integrity of cholesterol-rich membrane microdomains in which the colocalization and functional interaction of NMDAR-transferred calcium influx, calcium extrusion by NCX, and Na/K-ATPase modulation of the exchanger occur. This regulation of the molecules by cardiotonic steroids may influence synaptic transmission, prevent excitotoxic neuronal death, and interfere with the pharmacological actions of neurological medicines.

27 November 2019 in Neuroscience and Behavioral Physiology
Verified
Journal Article
Closed access
PDF file
MIM. A. Ivanova
M. A. Ivanova
LSL. S. Sitnikova
L. S. Sitnikova
TKT. V. Karelina
T. V. Karelina
Dmitry A SibarovDmitry A Sibarov
Dmitry A Sibarov
PAPolina A. A. Abushik
Polina A. A. Abushik
SAS. M. Antonov
S. M. Antonov

28 December 2017 in Journal of Molecular Neuroscience
Verified
Journal Article
Closed access
PDF file
Dmitry A SibarovDmitry A Sibarov
Dmitry A Sibarov
YSYulia D. Stepanenko
Yulia D. Stepanenko
ISIvan V. Silantiev
Ivan V. Silantiev
PAPolina A. Abushik
Polina A. Abushik
TKTatiana V. Karelina
Tatiana V. Karelina
Sergei M AntonovSergei M Antonov
Sergei M Antonov

Verified
Journal Article
Open access
PDF file
SBSergei Boikov
Sergei Boikov
Dmitry A SibarovDmitry A Sibarov
Dmitry A Sibarov
YSYulia D. Stepanenko
Yulia D. Stepanenko
TKTatiana V. Karelina
Tatiana V. Karelina
Sergei M AntonovSergei M Antonov
Sergei M Antonov
The facilitated activity of N-methyl-D-aspartate receptors (NMDARs) in the central and peripheral nervous systems promotes neuropathic pain. Amitriptyline (ATL) and desipramine (DES) are tricyclic antidepressants (TCAs) whose anti-NMDAR properties contribute to their analgetic effects. At therapeutic concentrations <1 µM, these medicines inhibit NMDARs by enhancing their calcium-dependent desensitization (CDD). Li+, which suppresses the sodium–calcium exchanger (NCX) and enhances NMDAR CDD, also exhibits analgesia. Here, the effects of different [Li+]s on TCA inhibition of currents through native NMDARs in rat cortical neurons recorded by the patch-clamp technique were investigated. We demonstrated that the therapeutic [Li+]s of 0.5–1 mM cause an increase in ATL and DES IC50s of ~10 folds and ~4 folds, respectively, for the Ca2+-dependent NMDAR inhibition. The Ca2+-resistant component of NMDAR inhibition by TCAs, the open-channel block, was not affected by Li+. In agreement, clomipramine providing exclusively the NMDAR open-channel block is not sensitive to Li+. This Ca2+-dependent interplay between Li+, ATL, and DES could be determined by their competition for the same molecular target. Thus, submillimolar [Li+]s may weaken ATL and DES effects during combined therapy. The data suggest that Li+, ATL, and DES can enhance NMDAR CDD through NCX inhibition. This ability implies a drug–drug or ion–drug interaction when these medicines are used together therapeutically.